Latest Cost Reduction Programs News

Qoria Limited updates shareholders on its proposed merger with Aura Consolidated Group, highlighting Aura's robust financial performance and cost-saving initiatives. The merger remains unanimously recommended by Qoria's board, pending regulatory and shareholder approvals.

Orica reports solid first-half earnings growth led by digital and specialty chemicals, while launching a $100 million cost reduction program to navigate supply disruptions and litigation headwinds.

Atomos Limited has reported a profitable first half of FY26 with revenue up 28%, driven by strong sales and cost discipline. The company reaffirms its full-year guidance, anticipating further growth and positive cash flow in the second half.

Experience Co Limited reported a 5% increase in sales revenue to $67.2 million for 1H26, with underlying EBITDA steady at $10.5 million despite operational challenges. The company is streamlining its portfolio by selling Wild Bush Luxury and focusing on scalable adventure experiences.

Compumedics Limited has reported a robust half-year performance, with revenue climbing 32% to $31 million and a return to profitability, driven by strong MEG system sales and SaaS growth.

Inghams Group reports flat revenue but a sharp 42% drop in EBITDA for the first half of FY26, revising full-year earnings guidance lower amid ongoing cost inflation and operational challenges.

Treasury Wine Estates reported a statutory loss driven by a significant US asset impairment but showed underlying growth in key markets. The company suspends its interim dividend and targets $100 million in annual cost savings through its TWE Ascent program.

Adheris Health has expanded its operating cost reduction program, aiming for more than 30% savings by FY27, while refocusing on high-growth pharmaceutical categories and enhancing its AI-powered patient engagement platform.

AMP Limited has revised its cost allocation and cost-to-income ratio methodology, restating prior business unit profits and setting FY26 cost guidance between $630 million and $640 million.

Compumedics has delivered record first-half sales orders and a 32% jump in shipped revenue, setting the stage for a robust second half driven by new product launches and operational efficiencies.

Coventry Group reports a challenging FY25 with revenue slipping 1.7% and EBITDA plunging 40.9%, but early FY26 results show promising recovery driven by cost cuts and ERP system stabilisation.

L1 Group Limited has completed its transformative merger between Platinum Asset Management and L1 Capital, creating a $16.7 billion funds under management powerhouse, backed by a $286 million capital raise to fuel growth.